Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2021
T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental GliomasMichael Kilian, Mirco Friedrich, Khwab Sanghvi, et al.
Science Advances|December 22, 2023
Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancerThorben Huth, Emely C Dreher, Steffen Lemke, et al.
Acta Neuropathologica Communications|November 21, 2013
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KGAnna C Navis, Simone P Niclou, Fred Fack, et al.
Molecular Cancer Therapeutics|May 27, 2020
A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in <i>BRAF</i>-Driven Pediatric Low-Grade Glioma CellsDiren Usta, Romain Sigaud, Juliane L Buhl, et al.
Frontiers in Immunology|March 18, 2025
Transkingdom mechanism of MAMP generation by chitotriosidase feeds oligomeric chitin from fungal pathogens and allergens into TLR2-mediated innate immune sensingTzu-Hsuan Chang, Yamel Cardona Gloria, Margareta J Hellmann, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 6, 2026
Strawberry Notch 1 Acts as a Transcriptional Regulator Driving Oncogenic Programs in Liver CarcinogenesisSarah Fritzsche, Raisatun Nisa Sugiyanto, Kira Gür, et al.
Scientific Reports|July 28, 2016
Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytomaSanne A M van Lith, Anna C Navis, Krissie Lenting, et al.
Acta Neuropathologica|May 8, 2019
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomasPeter Wirthschaft, Julia Bode, Himanshu Soni, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Pageof 9